is as sensitive and efficient as DNA sequencing in the ability to identify the sequence variations in the LDL receptor gene of the patients with heterozygous FH of this study.
INDEXING TERMS: familial hypercholesterolemia . mutation
More than 150 mutations in the LDL receptor gene have been characterized at the molecular level [1] , and increasing numbers of LDL receptor mutations are currently being described [2] . Mutations in the LDL receptor gene cause the autosomal dominant inherited disorder familial hypercholesterolemia (FH), characterized by increased plasma cholesterol, tendon xanthomata, and premature coronary artery disease [3] . The frequency of of homozygous FH is -1 in a million, and the gene frequency for heterozygous FH in most populations is -1 in 500, making heterozygous FH one of the most common serious genetic disorders [3] . Mutational analysis generally has two stages. The first identifies a region of the gene containing the mutation, and the second identifies the precise nature of the mutation by sequencing. For the first stage, various techniques for detecting sequence changes have been described, including denaturing gradient gel electrophoresis [4] [5] [6] [7] , chemical cleavage [8] , RNase cleavage [9] , and heteroduplex analysis [10, 11] . One of the most straightforward and widely used techniques is, however, the PCR-single-strand conformation polymorphism (PCR-SSCP) analysis [12, 13] , in which double-stranded DNA, amplified by PCR, is denatured to single-stranded DNA and separated in nondenaturing polyacrylamide gels to detect conformational changes due to changes in base sequence.
Because mutation detection has become an integrated part of
Nonstandard abbreviations: FH, familial hvpercholesterolemia; PCR-SSCP, polymerase chain reaction-single-strand conformation polymorphism; and apo, apolipoprotein. [14] were excluded by testing for the apo B-3500 mutation as previously described [15] . All patients' DNA samples were tested by Southern transfer analysis to exclude large gene rearrange- in Table I The oligonucleotide primers and the conditions used for the PCR-SSCP analysis described in Table I were also used for amplifying PCR products for sequence analysis and for the sequencing reaction with one exception: Exon 4 was amplified and sequenced in one part with the primers 5'-ACTGCG-GCAGCGTCCCCGGC-3'
(4as) and the following PCR program: 94#{176}C for 1 mm, 74#{176}C for 2 mm for a total of 35 cycles with a final extension of 10 mm at 74 #{176}C. We used solid-phase sequencing of chromosomal DNA [19] . This can be performed by PCR when one of the two primers is biotinylated.
We immobilized the double-stranded DNA on magnetic beads with covalently attached streptavidin.
We obtained immobilized single-stranded DNA, suitable for sequencing, by removing the unbound strand with alkali. To be able to sequence both the sense and the antisense strand, we used four primers: sense primer with and without biotin and antisense primer with and without biotin as shown in Fig. 1 [20] .
Results
Oligonucleotide primers were designed to amplify the promoter region, the translated exon sequences, and the flanking intron sequences of all 18 exons of the LDL receptor gene (Table 1 ). In addition to 9 SSCP variants representing known polymorphisms already reported [21] [22] [23] [24] [25] [26] [27] [28] [29] (Table 2) , 13 other conformational variants representing different mutations were observed during the PCR-SSCP analysis at room temperature with and without 50 mL/L glycerolin the gel (Table 3) .Detection of variants depended on the use of glycerolin the gel.All the known polymorphic variants (Table 2 ) and 92% (12 of 13) of other variants (Table 3) were visible when glycerolwas used,whereas the absence of glycerolresultedin detectionof only 67% (6 of 9) of the polymorphic variantsand 69% (9 of 13) of the other variants. Running gelswith and without glycerolensured detection of all mutations.
Figs. 2 and 3 show examples of such SSCP variantsand subsequent sequencing results. Importantly, direct sequencing of the PCR products did not reveal sequence variations not observed in the PCR-SSCP analysis.
We identified 13 different mutations (Table 3) of which nine (W23X [11] , W66G [30] , 313+IG-*A [31] [32] [33] , El 19K [34] , 335de110 [35] , C1056T [36] , l65OdelG [37] ,
1846-1G-*A[38],
T7051 [11] ) already have been described.The remaining four mutations described here have not to our knowledge been reported before.In exon 9, one patientwas heterozygous foran A to C transversionthat changes amino acid threonine in position383 to proline(T383P). In exon 12 we detecteda G to C transversion resulting in a change of tryptophan to serine
(W5565).
In one patient with the W66G mutation, we identified a silentC to T transition in exon 10 not changing the coding amino acid asparaginein position494. Interestingly, the novel splice-site mutation 1061 -8T-C was identified in a patient with two other mutations, 335de110 and T7051. Family studies revealed that these three mutations were situated on the same allele. In two of the 20 patients we could not detect any sequence variants other than well-known polymorphisms by either PCR-SSCP analysis or sequencing.
Discussion
PCR-SSCP analysis istechnically a simple method fordetecting sequence variations that has been used for mutational analysis of various genes [39] , including the LDL receptor gene [1, [40] [41] [42] . Many factors can influence the sensitivity of PCR-SSCP analysis. The sensitivity of the method depends on the length of the amplified fragments, the electrophoretic conditions, the extent of cross-linking concentration of acrylamide, and the presence or absence of glycerol [39, 43] . There are, however, discrepancies in the reported sensitivity of this technique.
Detection rates in different studies including the LDL receptor gene involving conventional SSCP can be as low as 50%, but in almost half of the experiments it was 100% [39] , and, in general, the sensitivity of the method is very high when appropriate conditions are chosen [39, 42, 43] . Sensitivity is especially highest when the PCR fragment is smaller than 200 -300 bp [391. The position of a single base substitution seems to be more important than the type of mutation (transversion vs transition) in determining whether a mutation is detected [43] . The sensitivity of a mutation detection method has usually been evaluated by the rateof detection of already known mutations. However, a more definitiveevaluation of the sensitivity of such a mutation screening method isto compare the rate of detected sequence variationswith the resultsof DNA sequencing of the same amplified fragments, assuming, of course, that the sequencing method used actually is capable of detecting all sequence variations. (Tables 2 and 3 ). SSCP analysis with and without glycerol therefore seems necessary to obtain high sensitivity of mutation detection.
The high resolution capacity of PCR-SSCP as performed here was apparent in the analysis of exon 12, which contained two different polymorphisms that were distinguishable when either was present without the other as well as when both were present.
It was also possible to identify a novel sequence variation, the W556S mutation, in the same exon 12 fragment. Although we obtained 100% sensitivity of the PCR-SSCP method as compared with DNA sequencing in mutation detection for the mutations examined, mutations not evaluated in this study possibly would require other running conditions to be detected. Therefore, caution should be taken in generalizing from our data because they pertain in principle only to the specific mutations examined. Besides the nine well-characterized polymorphisms ( LDL receptor gene mutation, as previously described [35] , deletes 10 nucleotides, resulting in a translational frameshift in exon 4, a following stop codon, and a truncated LDL receptor protein lacking the epidermal growth factor precursor homology region, the 0-linked sugar region, the membrane spanning region, and the cytoplasmic tail of the receptor.
The two other mutations in intron 7 and exon 15 therefore have no functional significance in that mutant allele. The T7051 mutation as single mutation, however, has been suggested to cause FH [1] , whereas it remains to be established whether the 1061 -8T--*C acceptor splice mutation would be pathogenic by affecting mRNA splicing. We did not identify any aberrant SSCP pattern or sequence variation either in the 277-bp amplified promoter region or in exons 1, 5, 6, 14, 16, and 18. However, in other FH subjects not included in this study, we were able to detect sequence variations in the promoter region, the C(-43)T mutation [44] , in exon 5, a novel C222R mutation (unpublished data), and in exon 6, the S285L mutation described by others [1] .
In two of the 20 clinically diagnosed heterozygous FH patients, the PCR-SSCP analysis and sequence analysis did not reveal any sequence variations except already described polymorphisms.
In addition, we excluded large gene rearrangements by Southern transfer. The exclusion of pathogenic mutations in the promoter region and in the 18 exons including flanking intron splice-site consensus sequences suggests that FH in these two patients could be due to mutations either in other parts of the LDL receptor gene not included in our investigation, e.g., the 3 '-untranslated region, or in other genes of importance for plasma LDL cholesterol concentrations.
One possibility is the apo B gene, although patients with the apo B-3500 mutation were excluded from this study.
In conclusion, the PCR-SSCP method described here is as sensitive and efficient as DNA sequencing in the ability to identify the sequence variations in the LDL receptor gene of the patients with heterozygous FH of this study. 
